Insights

Product Innovation Par Pharmaceutical's focus on developing safe, innovative, and cost-effective generic products, including sterile injectables and alternative dosage forms, positions it to serve healthcare providers seeking diverse pharmaceutical solutions, creating opportunities to expand its market share through tailored offerings.

Recent Product Launches The launch of a generic ibuprofen-famotidine medication and the recent debut of the DUEXIS generic indicates ongoing product innovation and market entry, presenting opportunities for sales teams to promote additional generics and strengthen relationships with healthcare providers and pharmacies.

Recall and Quality Opportunities The voluntary recall of treprostinil injection highlights a focus on product safety and quality improvements, opening avenues to position alternative or improved formulations to clients concerned about quality assurance and regulatory compliance.

Similar companies to Par Pharmaceutical

Par Pharmaceutical Tech Stack

Par Pharmaceutical uses 8 technology products and services including AutoCAD, Salesforce, Microsoft Excel, and more. Explore Par Pharmaceutical's tech stack below.

AutoCAD
Cad & Graphics
Salesforce
Customer Relationship Management
Microsoft Excel
Editors
Microsoft PowerPoint
Editors
Font Awesome
Font Scripts
Kronos
Human Resource Management System
ADP
Human Resource Management System
Microsoft
Miscellaneous

Media & News

Par Pharmaceutical's Email Address Formats

Par Pharmaceutical uses at least 1 format(s):

Par Pharmaceutical Email Formats	Example	Percentage
First.Last@parpharm.com	John.Doe@parpharm.com	65%
L.First@parpharm.com	D.John@parpharm.com	25%
FLast@parpharm.com	JDoe@parpharm.com	8%
First.L@parpharm.com	John.D@parpharm.com	2%

Frequently Asked Questions

Where is Par Pharmaceutical's headquarters located?

Par Pharmaceutical's main headquarters is located at 1 Ram Ridge Road, Chestnut Ridge, NY 10977, US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Par Pharmaceutical's stock symbol?

Par Pharmaceutical is a publicly traded company; the company's stock symbol is PRX.

What is Par Pharmaceutical's official website and social media links?

Par Pharmaceutical's official website is parpharm.com and has social profiles on LinkedIn.

How much revenue does Par Pharmaceutical generate?

As of October 2025, Par Pharmaceutical's annual revenue is estimated to be $935M.

What is Par Pharmaceutical's SIC code NAICS code?

Par Pharmaceutical's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Par Pharmaceutical have currently?

As of October 2025, Par Pharmaceutical has approximately 1.4K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: M. M.Chief Executive Officer: T. C.Chief Operations Officer: A. G.. Explore Par Pharmaceutical's employee directory with LeadIQ.

What industry does Par Pharmaceutical belong to?

Par Pharmaceutical operates in the Pharmaceutical Manufacturing industry.

What technology does Par Pharmaceutical use?

Par Pharmaceutical's tech stack includes AutoCADSalesforceMicrosoft ExcelMicrosoft PowerPointFont AwesomeKronosADPMicrosoft.

What is Par Pharmaceutical's email format?

Par Pharmaceutical's email format typically follows the pattern of First.Last@parpharm.com. Find more Par Pharmaceutical email formats with LeadIQ.

When was Par Pharmaceutical founded?

Par Pharmaceutical was founded in 1978.

Par Pharmaceutical

Pharmaceutical ManufacturingUnited States1001-5000 Employees

Par Pharmaceutical: High-Quality, Cost-Effective Generic Products

Par Pharmaceutical, headquartered in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products.  Par is an operating company of Endo International plc, a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.